The Adaptor Protein Crk Controls Activation and Inhibition of Natural Killer Cells

Immunity

Volumn 36, Issue 4, 2012, Pages 600-611

  Liu, Dongfang ^a   Peterson, Mary E ^a   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN CRK; CD16 ANTIGEN; CD94 ANTIGEN; CRK LIKE PROTEIN; HLA E ANTIGEN; IMMUNOGLOBULIN G1; NATURAL KILLER CELL RECEPTOR NKG2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL INHIBITION; CELL STIMULATION; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; LIPID BILAYER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SYNAPSE;

ACTINS; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; LIPID BILAYERS; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-CRK; RECEPTORS, IGG; RECEPTORS, NATURAL KILLER CELL; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84860007628     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.03.007     Document Type: Article

References (51)

1. Abeyweera T.P., Merino E., Huse M. Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J. Cell Biol. 2011, 192:675-690.
2. Almeida C.R., Davis D.M. Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density. J. Immunol. 2006, 177:6904-6910.
3. Anfossi N., André P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
4. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
5. Birge R.B., Kalodimos C., Inagaki F., Tanaka S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun. Signal. 2009, 7:13.
6. Brodin P., Kärre K., Höglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 2009, 30:143-149.
7. Bryceson Y.T., Ljunggren H.G., Long E.O. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009, 114:2657-2666.
8. Burshtyn D.N., Long E.O. Regulation through inhibitory receptors: Lessons from natural killer cells. Trends Cell Biol. 1997, 7:473-479.
9. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996, 4:77-85.
10. Chodniewicz D., Klemke R.L. Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold. Biochim. Biophys. Acta 2004, 1692:63-76.
11. Ciccone E., Pende D., Viale O., Than A., Di Donato C., Orengo A.M., Biassoni R., Verdiani S., Amoroso A., Moretta A., Moretta L. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 1992, 176:963-971.
12. Culley F.J., Johnson M., Evans J.H., Kumar S., Crilly R., Casasbuenas J., Schnyder T., Mehrabi M., Deonarain M.P., Ushakov D.S., et al. Natural killer cell signal integration balances synapse symmetry and migration. PLoS Biol. 2009, 7:e1000159.
13. Daëron M., Jaeger S., Du Pasquier L., Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol. Rev. 2008, 224:11-43.
14. Davis D.M., Chiu I., Fassett M., Cohen G.B., Mandelboim O., Strominger J.L. The human natural killer cell immune synapse. Proc. Natl. Acad. Sci. USA 1999, 96:15062-15067.
15. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
16. Dietrich J., Cella M., Colonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J. Immunol. 2001, 166:2514-2521.
17. Faure M., Barber D.F., Takahashi S.M., Jin T., Long E.O. Spontaneous clustering and tyrosine phosphorylation of NK cell inhibitory receptor induced by ligand binding. J. Immunol. 2003, 170:6107-6114.
18. Guerra N., Michel F., Gati A., Gaudin C., Mishal Z., Escudier B., Acuto O., Chouaib S., Caignard A. Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 2002, 100:2874-2881.
19. Guia S., Jaeger B.N., Piatek S., Mailfert S., Trombik T., Fenis A., Chevrier N., Walzer T., Kerdiles Y.M., Marguet D., et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci. Signal. 2011, 4:ra21.
20. Gupta N., Scharenberg A.M., Burshtyn D.N., Wagtmann N., Lioubin M.N., Rohrschneider L.R., Kinet J.P., Long E.O. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases. J. Exp. Med. 1997, 186:473-478.
21. Harwood N.E., Batista F.D. Early events in B cell activation. Annu. Rev. Immunol. 2010, 28:185-210.
22. Höglund P., Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nat. Rev. Immunol. 2010, 10:724-734.
23. Joncker N.T., Raulet D.H. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 2008, 224:85-97.
24. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., Raulet D.H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 2009, 182:4572-4580.
25. Kardava L., Moir S., Wang W., Ho J., Buckner C.M., Posada J.G., O'Shea M.A., Roby G., Chen J., Sohn H.W., et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J. Clin. Invest. 2011, 121:2614-2624.
26. Karlhofer F.M., Ribaudo R.K., Yokoyama W.M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992, 358:66-70.
27. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L.P., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., Yokoyama W.M. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
28. Liu D., Bryceson Y.T., Meckel T., Vasiliver-Shamis G., Dustin M.L., Long E.O. Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 2009, 31:99-109.
29. Long E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999, 17:875-904.
30. Long E.O. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008, 224:70-84.
31. March M.E., Long E.O. β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells. J. Immunol. 2011, 186:2998-3005.
32. Masilamani M., Nguyen C., Kabat J., Borrego F., Coligan J.E. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse. J. Immunol. 2006, 177:3590-3596.
33. Matsuda M., Tanaka S., Nagata S., Kojima A., Kurata T., Shibuya M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 1992, 12:3482-3489.
34. Mizutani T., Kondo T., Darmanin S., Tsuda M., Tanaka S., Tobiume M., Asaka M., Ohba Y. A novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells. Clin. Cancer Res. 2010, 16:3964-3975.
35. Nakashima N., Rose D.W., Xiao S., Egawa K., Martin S.S., Haruta T., Saltiel A.R., Olefsky J.M. The functional role of CrkII in actin cytoskeleton organization and mitogenesis. J. Biol. Chem. 1999, 274:3001-3008.
36. Olcese L., Lang P., Vély F., Cambiaggi A., Marguet D., Bléry M., Hippen K.L., Biassoni R., Moretta A., Moretta L., et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 1996, 156:4531-4534.
37. Peterson M.E., Long E.O. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 2008, 29:578-588.
38. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84-89.
39. Reedquist K.A., Ross E., Koop E.A., Wolthuis R.M., Zwartkruis F.J., van Kooyk Y., Salmon M., Buckley C.D., Bos J.L. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 2000, 148:1151-1158.
40. Riteau B., Barber D.F., Long E.O. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J. Exp. Med. 2003, 198:469-474.
41. Schleinitz N., March M.E., Long E.O. Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS ONE 2008, 3:e3278.
42. Segovis C.M., Schoon R.A., Dick C.J., Nacusi L.P., Leibson P.J., Billadeau D.D. PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion. J. Immunol. 2009, 182:6933-6942.
43. Standeven L.J., Carlin L.M., Borszcz P., Davis D.M., Burshtyn D.N. The actin cytoskeleton controls the efficiency of killer Ig-like receptor accumulation at inhibitory NK cell immune synapses. J. Immunol. 2004, 173:5617-5625.
44. Stebbins C.C., Watzl C., Billadeau D.D., Leibson P.J., Burshtyn D.N., Long E.O. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 2003, 23:6291-6299.
45. ten Hoeve J., Morris C., Heisterkamp N., Groffen J. Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 1993, 8:2469-2474.
46. Tolar P., Sohn H.W., Pierce S.K. Viewing the antigen-induced initiation of B-cell activation in living cells. Immunol. Rev. 2008, 221:64-76.
47. Tybulewicz V.L. Vav-family proteins in T-cell signalling. Curr. Opin. Immunol. 2005, 17:267-274.
48. Varma R., Campi G., Yokosuka T., Saito T., Dustin M.L. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 2006, 25:117-127.
49. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
50. Vyas Y.M., Mehta K.M., Morgan M., Maniar H., Butros L., Jung S., Burkhardt J.K., Dupont B. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J. Immunol. 2001, 167:4358-4367.
51. Yokoyama W.M., Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 2006, 214:143-154.